Skip to main content
CBTCabot CorporationHold6.0·$91.05+1.88%
HoldModerate Confidence
Investment thesis

Cabot Corporation has built a credible earnings track record with four consecutive beats and exceptional free cash flow conversion, but the stock has already traded through its near-term resistance target with revenues in structural decline — the setup favors patience over fresh commitment at current levels.

Thesis pillars

  • Revenue Decline Structural HeadwindStable
  • Attractive Valuation Golden CrossStable
  • Price Above Near Term TargetDeteriorating
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Cabot Corporation (CBT) Stock Analysis

HoldGrowthQualityModerate Confidence

Basic Materials · Specialty Chemicals

Earnings in 6 days (2026-08-03). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $91.05, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.7% away).

Cabot Corporation manufactures specialty chemicals and performance materials across two segments—Reinforcement Materials (carbon black for tires and industrial products) and Performance Chemicals (specialty carbons, battery materials, fumed metal oxides, inkjet colorants)—with... Read more

$91.05-12.9% A.UpsideScore 6.0/10#14 of 41 Specialty Chemicals
QualityF-score6 / 9FCF yield8.11%
IncomeYield2.05%(5y avg 2.15%)Payout33.96%sustainable
Stop $85.89Target $91.13(resistance)A.R:R -1.2:1
Analyst target$91.17+0.1%6 analysts
$91.13our TP
$91.05price
$91.17mean
$70
$102

Hold if already holding. Not a fresh buy at $91.05, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.7% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.

Passes 5/8 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Aug 3, 20266d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Earnings estimates trending UP
Attractive valuation
Risks
Analyst target reached - limited upside remaining
Near 52-week high (3.7% away)
Earnings in 6 days (event risk)

Key Metrics

P/E (TTM)17.0
P/E (Fwd)12.7
Mkt Cap$4.6B
EV/EBITDA7.7
Profit Mgn8.0%
ROE20.0%
Rev Growth-3.4%
Beta0.82
Dividend2.05%
Rating analysts11

Quality Signals

Piotroski F6/9

Options Flow

P/C2.56bearish
IV53%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.5<4.5A.R:R -1.2=NEGATIVEEARNINGS PROXIMITY 6d<=7dInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
76 · Overbought
20D MA 50D MA 200D MAGOLDEN CROSSSupport $81.60Resistance $92.99

Price Targets

$86
$91
A.Upside-12.9%
A.R:R-1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-12.9% upside)
! momentum at 4.5 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-03 (6d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CBT stock a buy right now?

Hold if already holding. Not a fresh buy at $91.05, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.7% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $91.13 (+0.1%), stop $85.89 (−6.0%), A.R:R -1.2:1. Score 6.0/10, moderate confidence.

What is the CBT stock price target?

Take-profit target: $91.13 (-12.9% upside). Target $91.13 (+0.1%), stop $85.89 (−6.0%), A.R:R -1.2:1. Stop-loss: $85.89.

What are the risks of investing in CBT?

Analyst target reached - limited upside remaining; Near 52-week high (3.7% away); Earnings in 6 days (event risk).

Is CBT overvalued or undervalued?

Cabot Corporation trades at a P/E of 17.0 (forward 12.7). TrendMatrix value score: 7.6/10. Verdict: Hold.

What do analysts say about CBT?

11 analysts cover CBT with a consensus score of 3.5/5. Average price target: $91.

What does Cabot Corporation do?Cabot Corporation manufactures specialty chemicals and performance materials across two segments—Reinforcement...

Cabot Corporation manufactures specialty chemicals and performance materials across two segments—Reinforcement Materials (carbon black for tires and industrial products) and Performance Chemicals (specialty carbons, battery materials, fumed metal oxides, inkjet colorants)—with plants in the U.S. and over 20 other countries. Sales in China constituted approximately 25% of fiscal 2025 revenues; the company employed approximately 4,100 people globally at September 30, 2025.

Related stocks: SQM (Sociedad Quimica y Minera S.A.) · WDFC (WD-40 Company) · ALB (Albemarle Corporation) · MTX (Minerals Technologies Inc.) · FUL (H. B. Fuller Company)
Home Stocks CBT

Latest news

Latest News

Yahoo Finance93d ago
CBT News16d agoBankruptcy
MarketBeat17d ago
GuruFocus79d agoAnalyst
CBT News80d ago
MSN86d ago
MarketBeat86d agoAnalyst
CBT News59d ago
Dars.gov.et31d ago
GuruFocus32d ago
MarketBeat94d agoEarnings
TradingKey39d ago
Traders Union11d ago
Zacks Investment Research17d ago
CBT News80d agoProduct
CBT News81d ago
Mshale52d ago
CBT News52d ago
Moomoo25d ago
MarketBeat88d agoAnalyst
Loading more...